Results 201 to 210 of about 16,087 (221)

Dapagliflozin improves steatohepatitis in diabetic rats via inhibition of oxidative stress and inflammation

International Immunopharmacology, 2022
Moustafa Y, Reem Hazem
exaly  

Dapagliflozine

Nursing, 2021
openaire   +1 more source

Amelioration of diastolic dysfunction by dapagliflozin in a non-diabetic model involves coronary endothelium

Pharmacological Research, 2020
Konrad Urbanek, Carmela Dell'Aversana, Antonella De Angelis   +2 more
exaly  

Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age

Circulation, 2020
Sergey Tereshchenko, Marc Sabatine
exaly  

Synthesis of metabolites of dapagliflozin: an SGLT2 inhibitor

Journal of Chemical Sciences, 2020
Kishore Karumanchi
exaly  

Efficacy and Safety of Dapagliflozin in the Elderly: Analysis From the DECLARE–TIMI 58 Study

Diabetes Care, 2020
Nikolaus Marx, Marc Sabatine, Lawrence Leiter   +2 more
exaly  

Effect of a high‐fat meal on the pharmacokinetics of dapagliflozin, a selective SGLT2 inhibitor, in healthy subjects

Diabetes, Obesity and Metabolism, 2011
Marc Pfister
exaly  

Dapagliflozin in patients with type 2 diabetes mellitus: A pooled analysis of safety data from phase IIb/III clinical trials

Diabetes, Obesity and Metabolism, 2018
Jochen Seufert, André Scheen, Serge Jabbour   +2 more
exaly  

Correction of anemia by dapagliflozin in patients with type 2 diabetes

Journal of Diabetes and Its Complications, 2020
Peter Greasley, Hiddo Lambers Heerspink, Ricardo Correa-Rotter   +2 more
exaly  

Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin versus glimepiride as add‐on to metformin in patients with type 2 diabetes

Diabetes, Obesity and Metabolism, 2018
Jochen Seufert, Dirk Müller-Wieland, Katarzyna Cypryk   +2 more
exaly